Wilson JM - Search Results

1

Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia.

Kolansky DM, Cuchel M, Clark BJ, Paridon S, McCrindle BW, Wiegers SE, Araujo L, Vohra Y, Defesche JC, Wilson JM, Rader DJ. Kolansky DM, et al. Among authors: wilson jm. Am J Cardiol. 2008 Dec 1;102(11):1438-43. doi: 10.1016/j.amjcard.2008.07.035. Epub 2008 Sep 11. Am J Cardiol. 2008. PMID: 19026292

2

Therapeutic strategies for familial hypercholesterolemia based on somatic gene transfer.

Wilson JM, Grossman M. Wilson JM, et al. Am J Cardiol. 1993 Sep 30;72(10):59D-63D. doi: 10.1016/0002-9149(93)90012-2. Am J Cardiol. 1993. PMID: 8213498 Free article. Review.

3

Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia.

Raper SE, Grossman M, Rader DJ, Thoene JG, Clark BJ 3rd, Kolansky DM, Muller DW, Wilson JM. Raper SE, et al. Among authors: wilson jm. Ann Surg. 1996 Feb;223(2):116-26. doi: 10.1097/00000658-199602000-00002. Ann Surg. 1996. PMID: 8597504 Free PMC article. Clinical Trial.

4

Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor.

Chen SJ, Rader DJ, Tazelaar J, Kawashiri M, Gao G, Wilson JM. Chen SJ, et al. Among authors: wilson jm. Mol Ther. 2000 Sep;2(3):256-61. doi: 10.1006/mthe.2000.0122. Mol Ther. 2000. PMID: 10985956 Free article.

5

Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia.

Lebherz C, Gao G, Louboutin JP, Millar J, Rader D, Wilson JM. Lebherz C, et al. Among authors: wilson jm. J Gene Med. 2004 Jun;6(6):663-72. doi: 10.1002/jgm.554. J Gene Med. 2004. PMID: 15170737

6

Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production.

Millar JS, Maugeais C, Ikewaki K, Kolansky DM, Barrett PH, Budreck EC, Boston RC, Tada N, Mochizuki S, Defesche JC, Wilson JM, Rader DJ. Millar JS, et al. Among authors: wilson jm. Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):560-5. doi: 10.1161/01.ATV.0000155323.18856.a2. Epub 2005 Jan 6. Arterioscler Thromb Vasc Biol. 2005. PMID: 15637307

7

Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalpha.

Lehrke M, Lebherz C, Millington SC, Guan HP, Millar J, Rader DJ, Wilson JM, Lazar MA. Lehrke M, et al. Among authors: wilson jm. Cell Metab. 2005 May;1(5):297-308. doi: 10.1016/j.cmet.2005.04.005. Cell Metab. 2005. PMID: 16054077 Free article.

8

Creatine kinase, a magnetic resonance-detectable marker gene for quantification of liver-directed gene transfer.

Li Z, Qiao H, Lebherz C, Choi SR, Zhou X, Gao G, Kung HF, Rader DJ, Wilson JM, Glickson JD, Zhou R. Li Z, et al. Among authors: wilson jm. Hum Gene Ther. 2005 Dec;16(12):1429-38. doi: 10.1089/hum.2005.16.1429. Hum Gene Ther. 2005. PMID: 16390274

9

Complete prevention of atherosclerosis in apoE-deficient mice by hepatic human apoE gene transfer with adeno-associated virus serotypes 7 and 8.

Kitajima K, Marchadier DH, Miller GC, Gao GP, Wilson JM, Rader DJ. Kitajima K, et al. Among authors: wilson jm. Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1852-7. doi: 10.1161/01.ATV.0000231520.26490.54. Epub 2006 Jun 8. Arterioscler Thromb Vasc Biol. 2006. PMID: 16763161

10

Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent.

Lebherz C, Sanmiguel J, Wilson JM, Rader DJ. Lebherz C, et al. Among authors: wilson jm. Cardiovasc Diabetol. 2007 May 2;6:15. doi: 10.1186/1475-2840-6-15. Cardiovasc Diabetol. 2007. PMID: 17475009 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,835 results

Search Page